Europe’s hepatitis challenge: Defusing the “viral time bomb”

References 

1. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127:5–16
   • Full Text
   • Full-Text PDF (40 KB)
   • CrossRef
2. Bosetti C, Levi F, Boffetta P, Lucchini F, Negri E, La Vecchia C, et al. Trends in mortality from hepatocellular carcinoma in Europe, 1980–2004. Hepatology. 2008;48:137–145
   • CrossRef
3. World Health Organisation, Viral Cancers Fact Sheet. http://www.who.int/vaccine_research/diseases/viral_cancers/en/index2.html.
4. Eurasian Harm Reduction Network (EHRN), “HCV Infection in Europe”, http://www.ihra.net/Assets/484/1/CEEHRNReportHCVInfectioninEurope2007.pdf [01.10.07].
5. ELPA Members Survey, Autumn 2008.
6. http://www.europarl.europa.eu/sides/getDoc.do?objRefId=93641&language=EN.
7. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2003:165:0031:0033:EN:PDF.
8. ELPA/EASL Expert Recommendations for the Promotion of case-finding for Viral Hepatitis B and C, including targeted screening measures for risk groups; February 2009.
9. BBC Online, Primary liver cancers ‘soaring’; 19 August 2009. http://news.bbc.co.uk/2/hi/health/8210208.stm.
10. Cancer Research UK statistics, publicly. http://info.cancerresearchuk.org/cancerstats/types/liver/.